Pluton Biosciences, LLC — Form C/A (Regulation Crowdfunding)
Pluton Biosciences, LLC of St. Louis, MO filed a Form C/A (Regulation Crowdfunding) with the SEC on 2019-05-01. Target raise $75K, up to $150K. Offered through Nvsted.
Offering
- Filed: 2019-05-01
- Form: C/A
- Accession: 0001759355-19-000009
- Target amount: $75K
- Maximum amount: $150K
- Security type: Debt
- Deadline: 2019-06-07
- Funding portal / intermediary: Nvsted
- Intermediary file number: 007-00111
- Intermediary CRD: 288930
Issuer
- CIK: 0001759355
- Website: https://plutonbio.com
- Legal status: Limited Liability Company
- Organized in: MO
- Incorporated: 2017-01-17
- Address: 312 Planthurst Rd, St. Louis, MO, 63119
- Employees: 4
Financials (as filed)
- Total assets (most recent): $57K
- Cash (most recent): $46K
- Net income (most recent): $-113K
- Long-term debt: $375K
People (7)
| Name | Role | Location |
|---|
| Glendon Schuster | CTO, Member, Board of Managers | Clayton, MO |
| Barry Goldman | CEO and Chief Scientific Officer, Co-Founder | ST. LOUIS, MO |
| Barry Goldman | Science Advisor, Co-Founder | ST. LOUIS, MO |
| Charlie Walch | CBO | St. Louis, MO |
| Charlie Walch | CBO, Co-Founder | St. Louis, MO |
| Charlie Walch | CEO | St. Louis, MO |
| Charlie Walch | CEO, Co-Founder | St. Louis, MO |
Reg CF filing history (5)
More